2015
DOI: 10.1016/j.respe.2015.03.022
|View full text |Cite
|
Sign up to set email alerts
|

Tendances temporelles de l’utilisation hors indications de l’autorisation de mise sur le marche (AMM) de l’éculizumab (SOLIRIS®) et étude de l’impact des publications

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles